Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
Bokemeyer C, Oechsle K, Honecker F, Mayer F, Hartmann JT, Waller CF, Böhlke I, Kollmannsberger C; German Testicular Cancer Study Group. Bokemeyer C, et al. Among authors: mayer f. Ann Oncol. 2008 Mar;19(3):448-53. doi: 10.1093/annonc/mdm526. Epub 2007 Nov 15. Ann Oncol. 2008. PMID: 18006893 Free article. Clinical Trial.
UFT/calcium folinate plus weekly paclitaxel for solid tumors.
Bokemeyer C, Hartmann JT, Kollmannsberger C, Mayer F, Kanz L. Bokemeyer C, et al. Among authors: mayer f. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):106-11. Oncology (Williston Park). 1999. PMID: 10442376 Free article. Clinical Trial.
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
Bokemeyer C, Hartmann JT, Mayer F, Böhlke I, Kanz L, Von Pawel J, Derigs G, Schröder M. Bokemeyer C, et al. Among authors: mayer f. Oncology (Williston Park). 2000 Oct;14(10 Suppl 9):63-7. Oncology (Williston Park). 2000. PMID: 11098497 Free article. Clinical Trial.
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.
Oechsle K, Honecker F, Cheng T, Mayer F, Czaykowski P, Winquist E, Wood L, Fenner M, Glaesener S, Hartmann JT, Chi K, Bokemeyer C, Kollmannsberger C. Oechsle K, et al. Among authors: mayer f. Ann Oncol. 2011 Dec;22(12):2654-2660. doi: 10.1093/annonc/mdr026. Epub 2011 Mar 17. Ann Oncol. 2011. PMID: 21415240 Free article. Clinical Trial.
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Joerger M, von Pawel J, Kraff S, Fischer JR, Eberhardt W, Gauler TC, Mueller L, Reinmuth N, Reck M, Kimmich M, Mayer F, Kopp HG, Behringer DM, Ko YD, Hilger RA, Roessler M, Kloft C, Henrich A, Moritz B, Miller MC, Salamone SJ, Jaehde U. Joerger M, et al. Among authors: mayer f. Ann Oncol. 2016 Oct;27(10):1895-902. doi: 10.1093/annonc/mdw290. Epub 2016 Aug 8. Ann Oncol. 2016. PMID: 27502710 Free article. Clinical Trial.
Late toxicity following curative treatment of testicular cancer.
Kollmannsberger C, Kuzcyk M, Mayer F, Hartmann JT, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: mayer f. Semin Surg Oncol. 1999 Dec;17(4):275-81. doi: 10.1002/(sici)1098-2388(199912)17:4<275::aid-ssu9>3.0.co;2-u. Semin Surg Oncol. 1999. PMID: 10588857 Review.
1,054 results